PPFIA1 and CCND1 are frequently coamplified in breast cancer

Genes Chromosomes and Cancer

Volumn 49, Issue 1, 2010, Pages 1-8

  Dancau, Ana Maria ^a   Wuth, Laura ^a   Waschow, Marcel ^a   Holst, Frederik ^a   Krohn, Antje ^a   Choschzick, Matthias ^a   Terracciano, Luigi ^b   Politis, Sotirios ^a   Kurtz, Stefan ^c   Lebeau, Annette ^a   Friedrichs, Kay ^d   Wencke, Katharina ^c,e   Monni, Outi ^f   Simon, Ronald ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF HAMBURG   (Germany)

^d Breast Center Hamburg   (Germany)

^e Altonaer Kinderkrankenhaus   (Germany)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; TAMOXIFEN;

ADULT; AGED; AMPLICON; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHROMOSOME 11Q; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE FUNCTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHENOTYPE; PPFIA1 GENE; PRIORITY JOURNAL; PROGNOSIS; TISSUE MICROARRAY; TREATMENT RESPONSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 11; CYCLIN D1; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; INCIDENCE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; TISSUE ARRAY ANALYSIS;

EID: 74949101075     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20713     Document Type: Article

References (33)

1. Al-Kuraya K, Schraml P, Torhorst J, Tapia C, Zaharieva B, Novotny H, Spichtin H, Maurer R, Mirlacher M, Kochli O, Zuber M, Dieterich H, Mross F, Wilber K, Simon R, Sauter G. 2004. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res 64:8534-8540.
2. Bièche I, Olivi M, Noquès C, Vidaud M, Lidereau R. 2002. Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays. Br J Cancer 86:580-586.
3. Bostner J, Waltersson MA, Fornander T, Skoog L, Nordenskjöld B, Stål O. 2007. amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer. Oncogene 26:6997-7005.
4. Clark ES, Brown B, Whigham AS, Kochaishvili A, Yarbrough WG, Weaver AM. 2008. Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Oncogene 28:431-444.
5. Courjal F, Louason G, Speiser P, Katsaros D, Zeillinger R, Theillet C. 1996. Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int J Cancer 69:247-253.
6. Freier K, Sticht C, Hofele C, Flechtenmacher C, Stange D, Puccio L, Toedt G, Radlwimmer B, Lichter P, Joos S. 2006. Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer 45:118-125.
7. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. 2004. Minireview: Cyclin D1: Normal and abnormal functions. Endocrinology 145:5439-5447.
8. Gaffey MJ, Frierson HFJ, Williams ME. 1993. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: Clinicopathologic correlations. Mod Pathol 6:654-659.
9. Gibcus JH, Kok K, Menkema L, Hermsen MA, Mastik M, Kluin PM, Wal JE, Schuuring E. 2007a. High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications. Hum Genet 121:187-201.
10. Gibcus JH, Menkema L, Mastik MF, Hermsen MA, de Bock GH, van Velthuysen ML, Takes RP, Kok K, Alvarez Marcos CA, van der Laan BF, van den Brekel MW, Langendijk JA, Kluin PM, van der Wal JE, Schuuring E. 2007b. Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Hum Cancer Biol 13:6257-6266.
11. Hofman P, Butori C, Havet K, Hofman V, Selva E, Guevara N, Santini J, Obberghen-Schilling EV. 2008. Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: Comparison with epidermal growth factor receptor status. Br J Cancer 98:956-964.
12. Hwang TS, Han HS, Hong YC, Lee HJ, Paik N-S. 2003. Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients. Pathol Int 53:74-80.
13. Ishii Y, Waxman S, Germain D. 2008. Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3. Cancer Res 68:852-860.
14. Järvinen A-K, Autio R, Haapa-Paananen S, Wolf M, Saarela M, Grénman R, Leivo I, Kallioniemi O, Mäkitie A, Monni O. 2006. Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene 25:6997-7008.
15. Jirström K, Stendahl M, Rydén L, Kronblad Å, Bendahl P-O, Stål O. 2005. Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification Cancer Res 65:8009-8016.
16. Karlseder J, Zeillinger R, Schneeberger C, Czerwenka K, Speiser P, Kubista E, Birnbaum D, Gaudray P, Theillet C. 1994. Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer 9:42-48.
17. Katoh M. 2005. Comparative genomics on mammalian Fgf3-Fgf4 locus. Int J Oncol 1:281-285.
18. Kenny FS, Hu R, Musgrove EA, Gee JMW, Blamey RW, Nicholson RI, Sutherland RL, Robertson JFR. 1999. Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer. Clin Cancer Res 5:2069-2076.
19. Kyomoto R, Kumazawa H, Toda Y, Sakaida N, Okamura A, Iwanaga M, Shintaku M, Yamashita T, Hiai H, Fukumoto M. 1997. Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer 74:576-581.
20. Leach FS, Elledge SJ, Sherr CJ, Willson JKV, Markowitz S, Kinzler KW, Vogelstein B. 1993. amplification of cyclin genes in colorectal carcinomas. Cancer Res 53:1986-1989.
21. Lin L, Hicks D, Xu B, Sigel JE, Bergfeld WF, Montgomery E, Fisher C, Hartke M, Tubbs R, Goldblum JR. 2005. Expression profile and molecular genetic regulation of cyclin D1 expression in epithelioid sarcoma. Mod Pathol 18:705-709.
22. Naidu R, Wahab NA, Yadav MM, Kutty MK. 2002. Expression and amplification of cyclin D1 in primary breast carcinomas: Relationship with histopathological types and clinico-pathological parameters. Oncol Rep 9:409-416.
23. Ormandy CJ, Musgrove EA, Hui R, Daly RJ, Sutherland RL. 2003. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 78:323-325.
24. Rudas M, Lehnert M, Huynh A, Jakesz R, Singer C, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Grill R, Stierer M, Gnant MW, Filipits M. 2008. Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy. Clin Cancer Res 14:1767-1774.
25. Ruiz C, Seibt S, Kuraya KA, Siraj AK, Mirlacher M, Schraml P, Maurer R, Spichtin H, Torhorst J, Popovska S, Simon R, Souter G. 2006. Tissue microarrays for comparing molecular features with proliferation activity in breast cancer. Int J Cancer 118:2190-2194.
26. Serra-Pages C, Kedersha NL, Fazikas L, Medleyl Q, Debant A, Streuli M. 1995. The LAR transmembrane protein tyrosine phosphatase and a coiled-coil LAR-interacting protein co-localize at focal adhesions. EMBO J 14:2827-2838.
27. Serra-Pagès C, Medley QG, Tang M, Hart A, Streuli M. 1998. Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. J Biol Chem 273:15611-15620.
28. Serra-Pagès C, Streuli M, Medley QG. 2005. Liprin phosphorylation regulates binding to LAR: Evidence for liprin autophosphorylation. Biochemistry 44:15715-15724.
29. Shiraishi M, Noguchi M, Shimosato Y, Sekiya T. 1989. amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res 49:6474-6479.
30. Simon R, Nocito A, Hübscher T, Bucher C, Torhorst J, Schraml P, Bubendorf L, Mihatsch MM, Moch H, Wilber K, Schötzau A, Kononen J, Sauter G. 2001. Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst 93:1141-1146.
31. Stendahl M, Kronblad Å, Rydén L, Emdin S, Bengtsson NO, Landberg G. 2004. Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br J Cancer 90:1942-1948.
32. Tan KD, Zhu Y, Hiang KT, Rajasegaran V, Aggarwal A, Wu J, Hui YW, Hwang J, Lim DTH, Khee CS, et al. 2008. amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma. Genes Chromosomes Cancer 47:353-362.
33. Umekita Y, Ohi Y, Sagara Y, Yoshida H. 2002. Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients. Int J Cancer 98:415-418.